This gene therapy technique reversed the genetic derived hearing loss

Imagine if  you had a genetic disorder which resulted in you being both Blind and Deaf what would you do? This type of disorder is known as Usher Syndrome.

In Usher syndrome mutation occurs in at least 10 genes which can lead to the combination of deafness and blindness and its occurrence depends upon the gene which is mutated.Almost 125 million people around the world suffer with hearing loss due to genetic mutations.

Researchers are using gene therapy to see if they can treat this disease by editing its genetic basis for this disease . This was recently published in Nature that titled “Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c.”

Usher syndrome is generally classified into three types: Usher type 1, type 2 and 3. Usher I and II are usually common form, but only a small fraction of people from specific area  suffer from Usher III . In Type I Usher syndrome people are born deaf and they do not have the ability to hear or speak. Six genes are associated with this type of usher syndrome and the gene is involved in the formation of sensory hair bundles in the inner ear.

An adenoviral vector was utilized to re-introduce expression of a non mutated version of the gene USH1C in mice. Mutation of this gene causes Usher syndrome and leaves the mice deaf.

Gwenaëlle Géléoc and her colleagues from Boston Children’s Hospital in Massachusetts studied a newborn mice with a form of Usher syndrome type I. Firstly the mice was injected with a synthetic virus that carried a healthy version of the gene for a protein known as harmonin. This protein is usually present in the hair cells of the inner ear and helps in transmitting auditory signals to the brain. The researchers found out that the mice had given response to the gene very well and could listen to the sounds properly even as quiet as whisper like a normal mice. These mice also performed well in balance tests as normal mice.

Another study which was conducted by, Luk Vandenberghe at the Schepens Eye Research Institute of Massachusetts Eye and Ear in Boston and his colleagues found that the same virus delivered genes to a large number of the target hair cells in the mouse ear.

Treatment with the adenovirus during early stages of development resulted in a restoration in the mouse’s ability to hear.